Overdiagnosis of asthma in obese and nonobese adults

Aaron, Shawn D.; Vandemheen, Katherine L.; Boulet, Louis-Philippe; McIvor, R. Andrew; FitzGerald, J. Mark; Hernandez, Paul; Lemiere, Catherine; Sharma, Sat; Field, Stephen K.; Alvarez, Gonzalo G.; Dales, Robert E.; Doucette, Steve; Fergusso, Dean
November 2008
CMAJ: Canadian Medical Association Journal;11/18/2008, Vol. 179 Issue 11, p1121
Academic Journal
Background: It is unclear whether asthma is overdiagnosed in developed countries, particularly among obese individuals, who may be more likely than nonobese people to experience dyspnea. Methods: We conducted a longitudinal study involving nonobese (body mass index 20-25) and obese (body mass index = 30) individuals with asthma that had been diagnosed by a physician. Participants were recruited from 8 Canadian cities by means of random-digit dialing. A diagnosis of current asthma was excluded in those who did not have evidence of acute worsening of asthma symptoms, reversible airflow obstruction or bronchial hyperresponsiveness, despite being weaned off asthma medications. We stopped asthma medications in those in whom a diagnosis of asthma was excluded and assessed their clinical outcomes over 6 months. Results: Of 540 individuals with physician-diagnosed asthma who participated in the study, 496 (242 obese and 254 nonobese) could be conclusively assessed for a diagnosis of asthma. Asthma was ultimately excluded in 31.8% (95% confidence interval [CI] 26.3%-37.9%) in the obese group and in 28.7% (95% CI 23.5%-34.6%) in the nonobese group. Overdiagnosis of asthma was no more likely to occur among obese individuals than among nonobese individuals (p = 0.46). Of those in whom asthma was excluded, 65.5% did not need to take asthma medication or seek health care services because of asthma symptoms during a 6-month follow-up period. Interpretation: About one-third of obese and nonobese individuals with physician-diagnosed asthma did not have asthma when objectively assessed. This finding suggests that, in developed countries such as Canada, asthma is overdiagnosed.


Related Articles

  • High cost and resource use of undiagnosed paediatric asthma.  // PharmacoEconomics & Outcomes News;8/12/2006, Issue 509, p6 

    The article focuses on the costs and use of asthma medications prescribed to children with no asthma diagnosis, nonasthmatics and to those with diagnosed asthma. Cohort I and cohort II showed higher mean total nonasthma costs compared to the control group. The researchers observed that many...

  • Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthma. Lutfi, Mohamed Faisal // International Journal of Applied & Basic Medical Research;Mar2011, Vol. 1 Issue 1, p20 

    Background: In patients with advanced obstructive ventilatory disorders, expiration may last for a relatively long time until the end-of-test standards for forced vital capacity (FVC) are satisfied. This may be difficult for both the patient and the technician. The Forced expiratory volume in 3...

  • Do you need to read this article? Try this quiz.  // New Zealand Doctor;11/19/2008, p19 

    A quiz about asthma diagnosis and treatment is presented.

  • How asthma care is changing. Hall, Julie // Independent Nurse;8/4/2008, p27 

    The article features the recent innovations for the treatment of asthma in Great Britain. One of the recently made innovations includes the chloroflurocarbon (CFC)-containing preventers which require half-dose reduction due to particle size and are available as a breath-actuated product....

  • Occupational asthma. Snashall, D. // Occupational & Environmental Medicine;Oct2003, Vol. 60 Issue 10, p711 

    Discusses the attempts made by the British government to reduce occupational asthma. Key programs in a reduction strategy; Features of an approved code of practice which aimed to control substances that cause the disease; Introduction of ideas for reducing asthma at work.

  • Once daily oral controller therapy with low dose theophylline or montelukast was not effective in poorly controlled asthma.  // Evidence Based Medicine;Aug2007, Vol. 12 Issue 4, p115 

    The article comments on a study which examines whether adding once daily oral controller therapy to low dose theophylline or montelukast improves patient with poorly controlled asthma. The study found that once daily oral controller therapy with low dose theophylline or montelukast was not...

  • Pulling The Plug On Triggers: How To Send Asthma Allergens And Irritants Down The Drain. Madden, Julie A. // Internet Journal of Academic Physician Assistants;2002, Vol. 2 Issue 2, p15 

    Asthma is a condition in which the air passages in lungs, called bronchial tubes, are very sensitive to certain substances and are prone to becoming inflamed. It is important to identify triggers that can cause an asthma episode. Allergens are major cause of asthma. People with persistent asthma...

  • HEAVES. Bonner, Laurie; Freckleton, Melinda // Equus;Oct2012, Issue 421, p14 

    The article discusses the management of a horse with heaves, formally called recurrent airway obstruction (RAO), an asthma-like condition that causes coughing and labored breathing when airborne dusts, molds and other particles are inhaled by a sensitive horse. Heaves can lead to an allergic...

  • Comparative Efficacy of Budesonide by Different Delivery Devices in Bronchial Asthma. Rizvi, Dilshad Ali; Salman, Mohammad Tariq; Mahmood, Syed Esam; Sircar, Joydeep; Ansari, Karim Ullah; Verma, Vinod Kumar // National Journal of Physiology, Pharmacy & Pharmacology;2012, Vol. 2 Issue 2, p99 

    Aims& Objective: To assess the relative efficiency of budesonide administered from different delivery devices to adult patients of chronic stable bronchial asthma as measured by pulmonary function test parameters. Materials and Methods: This prospective study was undertaken to assess the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics